THE DEAL, AT A GLANCE
2/4 reviewedEmulate
01What it doesEmulate makes Organ-Chips, lab models of human organs for preclinical drug safety testing.Source-grounded · automated review · Explore ↗
Checked 2026-10-05 · Review due 2026-10-12
Read supporting source ↗Organ‑Chips are the human‑relevant alternative…
02What happenedEmulate raised $700M Seed, announced 2026-09-17From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersIts chips align with FDA and NIH encouragement of human-based alternatives to animal testing.Interpretation · Explore ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Emulate · Financing Record
Explore source-linked visual explanations for Emulate. Unsupported claims are withheld while source review continues.
Record 12476 · Recorded date: 2026-09-17
Explore company records →